LT - 1,1-Dimetiletil [(1S)-1-{[(2S,4R)-4-(7-chlor-4metoksiizochinolin-1-iloksi)-2-({(1R,2S)-1-[(ciklopropilsulfonil)karbamoil]-2-etenilciklopropil}karbamoil)pirolidin-1-il]karbonil}-2,2-dimetilpropil]karbamato ištirpinamų kapsulių kompozicija
EN - SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 9/48 |
(2006.01) |
|
|
A61K 31/4709 |
(2006.01) |
|
|
A61P 31/14 |
(2006.01) |
European patent
| (11) |
Number of the document |
2846780 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
13722217.0 |
|
Date of filing the European patent application |
2013-04-30 |
| (97) |
Date of publication of the European application |
2015-03-18 |
| (45) |
Date of publication and mention of the grant of the patent |
2018-07-18
|
| (46) |
Date of publication of the claims translation |
2018-11-12
|
PCT application
| (86) |
Number |
PCT/US2013/038770 |
|
Date |
2013-04-30 |
PCT application publication
| (87) |
Number |
WO 2013/169520 |
|
Date |
2013-11-14 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201261643454 P |
2012-05-07
|
US |
Inventors
| (72) |
PERRONE, Robert Kevin, US
|
Grantee
| (73) |
Bristol-Myers Squibb Holdings Ireland Unlimited Company,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
Attorney or representative
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
1,1-Dimetiletil [(1S)-1-{[(2S,4R)-4-(7-chlor-4metoksiizochinolin-1-iloksi)-2-({(1R,2S)-1-[(ciklopropilsulfonil)karbamoil]-2-etenilciklopropil}karbamoil)pirolidin-1-il]karbonil}-2,2-dimetilpropil]karbamato ištirpinamų kapsulių kompozicija |
| |
SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2019-03-21 |
7 |
162.00
EUR
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2020-04-30 |
